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c‑Jun N‑terminal kinase 1 (JNK1) 
modulates oligodendrocyte 
progenitor cell architecture, 
proliferation and myelination
Martina Lorenzati1,2, Enrica Boda1,2, Roberta Parolisi1,2, Martino Bonato2, Tiziana Borsello3,4, 
Thomas Herdegen5, Annalisa Buffo1,2* & Alessandro Vercelli1,2* 
During Central Nervous System ontogenesis, myelinating oligodendrocytes (OLs) arise from highly 
ramified and proliferative precursors called oligodendrocyte progenitor cells (OPCs). OPC architecture, 
proliferation and oligodendro‑/myelino‑genesis are finely regulated by the interplay of cell‑intrinsic 
and extrinsic factors. A variety of extrinsic cues converge on the extracellular signal‑regulated kinase/
mitogen activated protein kinase (ERK/MAPK) pathway. Here we found that the germinal ablation 
of the MAPK c‑Jun N‑Terminal Kinase isoform 1 (JNK1) results in a significant reduction of myelin in 
the cerebral cortex and corpus callosum at both postnatal and adult stages. Myelin alterations are 
accompanied by higher OPC density and proliferation during the first weeks of life, consistent with a 
transient alteration of mechanisms regulating OPC self‑renewal and differentiation. JNK1 KO OPCs 
also show smaller occupancy territories and a less complex branching architecture in vivo. Notably, 
these latter phenotypes are recapitulated in pure cultures of JNK1 KO OPCs and of WT OPCs treated 
with the JNK inhibitor D‑JNKI‑1. Moreover, JNK1 KO and WT D‑JNKI‑1 treated OLs, while not showing 
overt alterations of differentiation in vitro, display a reduced surface compared to controls. Our results 
unveil a novel player in the complex regulation of OPC biology, on the one hand showing that JNK1 
ablation cell‑autonomously determines alterations of OPC proliferation and branching architecture 
and, on the other hand, suggesting that JNK1 signaling in OLs participates in myelination in vivo.
During CNS development, myelin is produced by mature oligodendrocytes (OLs), whose cell processes spirally 
ensheathe discrete axon segments called  internodes1. Th s arrangement assures a high-speed action potential 
conduction along neuronal  axons2 and is instrumental to the achievement of impulse discharge synchrony 
among  neurons3.
Myelinating OLs originate from parenchymal precursors expressing the neuron-glia antigen 2 (NG2) chon-
droitin sulphate proteoglycan and the platelet derived growth factor receptor alpha (PDGFRα), commonly 
referred to as oligodendrocyte progenitor cells (OPCs)4. These cells initially amplify and colonize the entire 
CNS and maintain the proliferating ability even during adult  life5. Nevertheless, OPC overgrowth is constantly 
prevented by OPC-to-OPC repulsion. OPCs have a complex ramifi d morphology with multiple and dynamic 
processes that continuously scan the environment and repel each other through contact-mediated  inhibition6, 7. 
Th s assures the achievement of a “grid-like” homogenous cell distribution, where individual OPCs occupy 
non-overlapping domains. The progression of OPCs towards myelination is a multistep process that implies 
profound molecular changes and remarkable morphological  rearrangement8, 9. Both a cell-intrinsic program 
and environmental factors participate in the regulation of OPC architecture, proliferation and oligodendro-/
myelino-genesis. Extrinsic signals include contact-mediated and soluble factors provided by neurons and glial 
cells, including OPC  themselves8, 10. In spite of their origin, a variety of these cues converge on the extracellular 
signal regulated kinase/mitogen activated protein kinase (ERK/MAPK) pathway in OPCs/OLs11, 12, although the 
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identity and the specific role of the signal transduction players active in oligodendroglia at distinct functional 
phases remain poorly understood.
Among MAPKs, the c-Jun N-terminal kinases (JNKs) include three isoforms—JNK1, JNK2 and JNK3. While 
JNK1 and JNK2 are expressed ubiquitously, JNK3 expression is restricted to a few regions, including the  brain13. 
Despite this, in this latter region JNK1 seems to have a predominant role, as JNK1 KO mouse brain shows 
developmental  abnormalities14, including alterations in neuronal  specification15, microtubule  integrity16, 17, cell 
 migration18, dendritic and spine  architecture19, 20 and developmental  apoptosis21. Oligodendroglial cells are 
known to express all the three JNK  isoforms22. JNK3 has been consistently reported as a regulator of OPC/OL 
sensitivity to  apoptosis23–25 whereas the roles of JNK1 and JNK2  isoforms26 have not been investigated so far. 
Yet, the multifaceted contribution of JNK1 to neuronal development suggests this kinase may also exert multiple 
functions in non-neuronal cells, including oligodendroglia.
Here we found that the germinal ablation of JNK1 (JNK1 KO) results in a reduced expression of myelin 
proteins in the cerebral cortex and corpus callosum (CC) at both postnatal and adult stages. Th s occurred in 
spite of similar axonal densities in WT and JNK1 KO mouse cortex and CC. In these regions, OPC density and 
proliferation rate were higher during the fi st two weeks of life, consistent with the idea of alterations in mecha-
nisms regulating oligodendroglial proliferation and differentiation. Of note, JNK1 KO OPCs also showed smaller 
occupancy territories and a less complex branching architecture in vivo. These phenotypes were all recapitulated 
in pure cultures of JNK1 KO OPCs and WT OPCs treated with the JNK-inhibitor D-JNKI-1, indicating a cell-
autonomous role for JNK1 in the regulation of OPC amplifi ation and morphology. On the contrary, mutant 
and D-JNKI-1 treated OPCs did not show overt alterations of differentiation in vitro. However, they displayed 
a decreased surface extension suggesting that cell-autonomous factors may participate in cortical/CC hypomy-
elination in JNK1 KO mice. These data point to JNK1 as a novel player in the complex regulatory network of 
oligodendroglia functions and myelination.
Results
JNK1 KO mice display myelin abnormalities. In order to address the impact of JNK1 ablation on 
oligodendroglia, we fi stly examined the expression of the myelin marker MBP in the cerebral cortex. We found 
that JNK1 KO mice display a lower expression of MBP, both in infragranular and supragranular layers of the 
somatosensory cortex (Fig. 1A,C and Suppl. Fig. 1A,B) and in the CC (Fig. 1B,D). Th s defect was found at post-
natal ages (P7 and P15) and persisted at adult stages (P90). Myelin abnormalities, not only restricted to MBP 
expression, were also confi med by observation of WT and JNK1 KO Gallyas-stained sagittal sections (Suppl. 
Fig. 1C). Former studies on JNK1 KO revealed some extent of axonal  degeneration17. Thus, we asked whether the 
observed reduction of MBP and myelin refl cted the axonal regressive events. Indeed, the ratio of MBP/healthy 
axons (as detected by labelling of SMI31, a phosphorylated epitope of neurofilament H, a major component of 
the axonal cytoskeleton (Fig. 2A; Yandamuri et al.27)) appeared to be reduced in JNK1 KO cortices and CC com-
pared to WT, and the axon densities did not display a major decrease in mutant mice within the analyzed time 
window (Fig. 2A–D). These histological results were in line with western blotting (WB) analyses, which con-
fi med a reduction in the amount of other myelin-associated proteins, such as 2′,3′-Cyclic-Nucleotide 3′-phos-
phodiesterase (CNPase) and Myelin Oligodendrocyte Glycoprotein (MOG) (Fig. 2E,F and Suppl. Fig. 2A,B). On 
the whole, these results suggest hypomyelination in JNK1 KO mice. Also, myelin alterations were not merely 
attributable to a decrease of mature OLs in JNK1 KO mice as the densities of  CC1+ OLs were overall comparable 
to those of WTs in both cerebral cortex and CC (Suppl. Fig. 3A,B).
To assess whether changes in myelin levels in mutants were accompanied by alterations of the axo-mye-
linic arrangement, we examined the nodal/paranodal region by immunostaining against the paranodal protein 
 CASPR28, 29. Quantifi ation of  CASPR+ segments in the CC of adult brains revealed a signifi ant staining increase 
in JNK1 KO samples (Fig. 1E,F). Moreover, analyses of  CASPR+ node/paranode length showed a 17% increase 
in  CASPR+ segment length in mutants as compared to control mice (Fig. 1G). Of note, this latter feature is fre-
quently found in hypo-/dys-myelinating  conditions30, 31, corroborating the idea of myelin alterations in JNK1 
KO mice cortex and CC.
JNK1 KO cortical OPCs display enhanced proliferation early after birth and morphological 
alterations. As a second step, we expanded the investigation on OPCs and assessed their density, prolifera-
tion rate and apoptosis at different survival times (P7, P15 and P90). We found a signifi ant increase (about 
34%) in the density of PDGFRα+ OPCs at P7 and P15 in KO mice compared to WT, both in cerebral cortex and 
CC (Fig. 3A–C, representative images at P7) with no changes in cell distribution throughout the cortical layers 
(Suppl. Fig. 3C). Since the presence of a higher number of OPCs in the JNK1 KO cortex could result from either 
higher cell proliferation or decreased apoptosis (or a combination of the two), we counted PDGFRα+ duplets as 
a measure of proliferative  OPCs5, 32. At P7, the fraction of OPCs in duplets in JNK1 KO cortices was almost two-
fold higher than in WT, revealing that mutant OPCs have a higher proliferation rate than WT cells (Fig. 3D,E). 
Yet, the normal density (Fig. 3B,C) as well as the OPC proliferative fraction (Fig. 3E) of JNK1 KO OPCs appeared 
restored at adult stages (P90), suggesting a higher susceptibility of young OPCs to JNK1-dependent regulatory 
mechanisms. These results were also confi med by analyses of  NG2+/Ki67+ OPCs (Suppl. Fig. 3D).
Conversely, when we examined  NG2+ OPCs expressing activated caspase 3 (cCASP3) to detect ongoing 
apoptosis, co-expressing OPCs were barely detected in both WT and JNK1-KO mice (not shown). Similar results 
were also obtained by TUNEL staining (Suppl. Fig. 3E). These data point to JNK1 participation in the regulation 
of OPC proliferation, at least in a developmental time window.
Based on increased OPC density, we hypothesized that the territory occupied by each cell could also be 
altered in JNK1 KO cortices. This hypothesis was initially tested by the analysis of the Voronoi polygons, a tool 
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Figure 1.  Myelin alterations in JNK1 KO mouse cortex and CC. (A) Myelin distribution (red) in the cortex 
of P7, P15 and P90 WT vs JNK1KO mice. At P7 images illustrate the deep layers of the somatosensory cortex, 
at P15 and P90 images illustrate separately infragranular and supragranular cortical layers. (B) Representative 
images of MBP (red) distribution in P90 WT vs JNK1KO mice CC. (C, D) Quantifi ation of the percentage of 
 MBP+ pixels in the cortex (C) and in the CC (D) of P7, P15 and P90 WT vs JNK1KO mice. (E) Distribution 
of  CASPR+ paranodes in the CC of P90 WT vs JNK1KO mice, and (F) quantifi ation of the percentage of 
 CASPR+ pixels. (G) Quantifi ation of the length of CC  CASPR+ paranodes in P90 WT vs JNK1KO mice. Scale 
bars: 100 μm in (A) and (B), 10 μm in (E). WT wild type, P postnatal day, MBP Myelin Basic Protein, CASPR 
contactin-associated protein. *P < 0.05; **P < 0.01; ***P < 0.001.
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Figure 2.  Myelin alterations in JNK1 KO are not related to axonal abundance. (A)  MBP+ (red) and SMI31 
neurofilaments (green) expression in the cortex and CC of P7, P15 and P90 WT vs JNK1KO mice. At P7 images 
illustrate the deep layers of the motor cortex, nearby cingulum bundle. Quantifi ation of the percentage of  MBP+ 
(B), and SMI31 (C) pixels in the cortex and in CC of WT vs JNK1KO mice, and their ratio (D). (E) Western 
blots of P7, P15 and P30 WT and JNK1KO cortices and (F) corpora callosa. Full length blots are presented in 
Suppl. Fig. 5 (A—cortices, B—corpora callosa). Scale bars: 100 μm. WT wild type, P postnatal day, A.U. arbitrary 
units, MBP Myelin Basic Protein, SMI31 neurofilaments, CNPase 2′,3′-Cyclic-Nucleotide 3′-phosphodiesterase, 
MOG Myelin Oligodendrocyte Glycoprotein. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
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to analyze the spatial distribution of  cells33–35. Voronoi analysis suggested that, during early developmental stages 
(P7-P15), JNK1 KO OPCs occupied a less extended area than WT cells (Fig. 3F–I). To further corroborate these 
data and better understand the underlying cellular features, we performed morphometric analyses of both OPC 
somata and branches (Fig. 3J–L). Analyses at early and adult stages showed that OPC soma areas did not differ 
between WT and KO cells (Fig. 3K). However, in agreement with the Voronoi results, OPC territory (i.e. the area 
occupied by the entire OPC extension, including cell ramification) was significantly smaller in JNK1 KO than in 
WT (Fig. 3L). Yet, this decrease was no longer appreciated at adult stages (Fig. 3L). Nevertheless, at P90, JNK1 
KO OPCs displayed a shorter total length of ramifications with no changes in the number of primary ramifica-
tions (Fig. 3M,N) and a lower ratio of the number of branches over branch order (Fig. 3O). Thus, mutant OPC 
processes appeared less complex and overall less extended compared to the WT ones.
Taken together, these data indicate that JNK1 may play a role in the OPC proliferation and in the regulation 
of OPC branching architecture.
Cultured JNK1 KO OPCs reproduce proliferative and morphological alterations found 
in vivo. In order to disentangle whether JNK1 KO OPC alterations in vivo depended on other cell types or 
could be explained cell autonomously, we performed cultures of MACS-isolated OPCs derived from P0 WT or 
JNK1 KO mice and examined cell proliferation, apoptosis and morphology.
At first, we tested the occurrence of possible dysregulated expression of the other JNK isoforms, potentially 
accounting for compensatory mechanisms or functional alterations. However, levels of JNK2 and JNK3 expres-
sion in acutely isolated JNK1 KO cells, as tested by qRT-PCR, were comparable to those of WT cells (Suppl. 
Fig. 4C–E), thus confirming that we were assessing the consequence of JNK1 abrogation.
In culture, MACS-sorted JNK1 KO OPCs showed higher cell densities per fi ld (Fig. 4A–D) and a twofold 
higher proliferation rate compared to WT cells, as revealed by colocalization with the proliferative marker Ki67 
(Fig. 4A,B). Of note, while the proliferative fraction of WT cells decreased with increasing cell densities, the 
proliferative fraction of JNK1 KO OPCs remained constant, irrespective of the number of OPCs (Fig. 4C,D). 
As regards apoptosis, we found a threefold higher fraction of  cCASP3+ JNK1 KO OPCs compared to WT cells 
and an apoptotic rate decreasing with increasing densities in both KO and WT cells (Suppl. Fig. 4A,B). These 
data suggest that, although increased in KO cells, apoptosis is similarly regulated in both mutant and WT cells, 
whereas in mutant OPCs proliferative regulatory mechanisms may be altered as a consequence of JNK1 loss.
Moreover, morphometric analyses on non-proliferative isolated OPCs showed that JNK1 KO OPCs display a 
reduced ramifi ation complexity compared to WT cells (Fig. 4E,F–J) in the presence of similar soma area (Fig. 4F) 
and of a slightly higher number (about 12%) of primary ramifications (Fig. 4G). These results reveal that mutant 
OPCs show alterations independently of the presence of other cell types.
To confi m these results in a distinct experimental model, we investigated the effects of JNK inhibition 
obtained with the D-JNKI-1  inhibitor36 on rat OPC cultures. D-JNKI-1 is a cell penetrating peptide that prevents, 
through a competitive mechanism, the binding of JNK to both the scaffold protein JNK-interacting protein-1 
(JIP1) and its  substrates36–38. Of note, D-JNKI-1 does not act exclusively on the binding of JNK1, but also on 
that of JNK2 and JNK3. Analysis of Ki67 expression revealed a higher proliferative rate in OPCs treated with 
D-JNKI-1 compared to controls (Fig. 5A,B). Moreover, morphometric analyses highlighted branching altera-
tions resulting in a reduced ramifi ation complexity (Fig. 5C), thus resembling those of MACS-sorted JNK1 KO 
OPCs, as indicated by Sholl analysis (Fig. 5D).
Altogether these data show that JNK1 KO-related OPC functional and morphological abnormalities occur 
also independently of other cell types affected by the mutations and suggest that JNK1 is implicated in the regula-
tion of OPC proliferation and process architecture through a cell autonomous mechanism.
JNK1 KO OLs do not show overt differentiation defects in vitro but display reduced territory 
occupancy. In order to study whether JNK1 KO myelin alterations in vivo could be explained by an altered 
ability of JNK1 KO OLs to differentiate, we cultured MACS-isolated OPCs derived from P0 WT or JNK1 KO in 
non-proliferative conditions and examined MBP expression as well as cell morphology.
JNK1 KO and WT OLs in culture displayed equivalent capability to express MBP (Fig. 6A,B). Moreover, when 
we analyzed the frequency of immature vs mature  MBP+ cells, as distinguished by process complexity and by 
MBP localization (see “Methods”) we found no differences in JNK1 KO vs WT cells (Fig. 6C).
We also investigated the effects of JNK inhibition obtained with D-JNKI-136 on cultured rat OLs. Analysis 
of  MBP+ OLs confi med the results obtained for mutant OLs showing that D-JNKI-1 treated cells were able 
to differentiate, branch and form  MBP+ lamellae to the same extent of control cells (Fig. 6E–G). However, in 
both experimental conditions, the cell territory occupied by  MBP+ lamellae appeared reduced in JNK1 KO and 
D-JNKI-1 treated OLs (Fig. 6D,H).
Overall, these data show that the germinal ablation/inhibition of JNK1 does not affect the ability of OPCs to 
differentiate in  MBP+ OLs.
Discussion
The ERK/MAPK pathway is known to take part in the regulation of OPC architecture, proliferation and oligo-
dendro-/myelino-genesis11, 12. Among MAPKs, JNK1 contribution to oligodendroglial biology has been only 
marginally investigated so far. In this study, we found that constitutive JNK1 ablation in KO mice is associated 
with decreased expression of myelin proteins and myelin/paranodal abnormalities in the cerebral cortex and 
CC of postnatal and adult mice. Such alterations are accompanied by a transient increase in OPC density and 
proliferative ability and by a persistent reduction in OPC ramifi ations complexity. These abnormal features are 
also present in JNK1 KO OPCs cultures and in WT OPCs cultures treated with D-JNKI-1, indicating that cell 
6
Vol:.(1234567890)




Scientific Reports |         (2021) 11:7264  | https://doi.org/10.1038/s41598-021-86673-6
www.nature.com/scientificreports/
types distinct from oligodendroglial cells are not implicated in such alterations and suggesting a cell autonomous 
role of JNK1 in OPCs. On the other hand, JNK1 KO cultured OLs and D-JNKI-1 treated cells progress toward 
differentiation similarly to WT cells but displayed reduced lamellae-occupied territories, thus suggesting a cell-
autonomous contribution of JNK1 in the observed cortical/CC hypomyelination.
JNK1 and myelination. In the cerebral cortex of the mutant mice, we observed a lower expression of mye-
lin proteins and longer  CASPR+ paranodes, suggesting defic ts in myelin structure and alterations in myelinating 
OLs/axon crosstalk. Defective myelin deposition and alterations in the paranode length are two recurrent fea-
tures of hypo/dysmyelinating conditions linked to primary oligodendroglia  pathology30, 31. In vitro experiments 
indicate that JNK1 KO does not impair MBP expression or affect major steps of OL differentiation. However, 
morphological maturation in differentiating OLs appeared affected in mutant and treated cells, as lamellae-
occupied territories were reduced. Based on evidence that OL morphological or cytoskeletal alterations are often 
associated with reduced  myelination9, 39, it is conceivable that reduced membrane extension in mutant OLs may 
contribute to the hypomyelinated phenotype found in vivo. Although we did not observe overt degeneration in 
JNK1 KO axons at the examined ages and territories, former electron microscopy investigations revealed some 
extent of axonal degeneration in JNK1 KO  mice17, and showed that JNK1 takes part in microtubule maintenance 
and integrity, since earlier  ages16, 17. Microtubule dynamics both in neurons and oligodendrocytes play a fun-
damental role in OLs/neuron crosstalk, whose integrity is crucial for a correct  myelination40–43. On these bases, 
we cannot exclude subtle microtubule-related alterations in axons, myelin sheath formation and/or OLs/axon 
crosstalk could all take part in the hypomyelination phenotype observed in vivo in JNK1 KO. Further investiga-
tions are needed to clarify this issue.
JNK1 role in OPC proliferation and apoptosis. We also found that JNK1 KO OPCs display a higher 
proliferative rate associated with increased density at postnatal developmental stages, with no changes in their 
distribution through cortical layers. Th s feature suggests that JNK1 operates as a negative regulator of cell pro-
liferation in OPCs. According to in vitro experiments JNK1 appears to act in a cell autonomous fashion in cell 
division regulation in OPCs. However, it cannot be excluded that JNK1 KO OPCs could have been primed to an 
altered regulation of proliferation by environmental signals received at embryonic ages in vivo, so to determine 
their increased division rate also in purifi d culture conditions.
Notably, our observations apparently clash with the results of former studies showing JNK pathway (although 
without isoform specifi ations) as necessary for OPC proliferation upon incubation with the conditioned medium 
of neuroblastoma  cells44. However, on the other hand, JNK1 specific inhibition was shown to increase endothe-
lial cell division in controlled  conditions45, 46 or to have no effect in a carcinoma cell  line47. Moreover, in cancer 
development, JNK1 seems to play a dual role in promoting/inhibiting cell  proliferation48. Thus, literature data 
indicate a cell/context dependent role for JNK1 in the modulation of proliferative events.
OPC proliferation is fi ely tuned by two main mechanisms. One fi st mechanism appears to operate through 
an intracellular timer driven by the mitogen PDGF (Platelet-Derived Growth Factor), that determines when 
individual OPCs should stop dividing to proceed toward  differentiation49–51. One other mechanism implies OPC-
to-OPC contact-mediated inhibition of cell proliferation through, for instance, Netrin-1 (NT-1) and its receptor 
Deleted in Colorectal Cancer (DCC)  signaling6, 7. Of note, other sources of these contact-mediated inhibitors are 
unclear, although neurons have been shown to produce NT-17, 52. Former studies have implicated JNK1 activity 
as a positive regulator of cell cycle progression and a mediator of PDGF actions in  OPCs53. On the other hand, 
JNK1 was also reported to mediate NT-1/DCC signaling in neurons, suggesting that similar mechanisms could 
act also in oligodendroglia and, therefore, that JNK1 ablation could alter contact-mediated OPC proliferation 
 inhibition54. In vitro data appear to support this latter hypothesis, as they show that, at difference with WT cells, 
JNK1 KO OPC proliferative rate is maintained high also in conditions of elevated cell density.
Figure 3.  JNK1 loss increases OPC proliferation and alters OPC territory and architecture in vivo. (A) 
Distribution of PDGFRα+ OPCs (red) in WT vs JNK1KO cortex and CC (area between dotted lines) at 
P7. (B, C) Quantifi ation of PDGFRα+ OPCs in the dorsal cortex (B) and CC (C) at P7, P15 and P90. (D) 
Representative image of a PDGFRα+ (red) OPC duplet (i.e. juxtaposed sister cells just exiting cytokinesis and 
showing juxtaposed and symmetrical cell somata with decondensed grainy DAPI staining, yellow arrows) in the 
cortical grey matter. White arrow points to an individual non-newly generated OPC. DAPI (blue) counterstains 
cell nuclei. (E) Quantifi ation of the fraction of PDGFRα+ OPCs in duplets over the OPC population (as a 
measure of OPC division rate) at P7 and P90. (F) Distribution of  NG2+ OPCs (red) and construction of related 
Voronoi polygons in the cerebral cortex of P7 WT vs JNK1KO mice. Each Voronoi polygon is colour-coded 
according to the size of the area. DAPI (blue) counterstains cell nuclei. (G, H, I) Areas covered by the Voronoi 
polygons in (G) P7, (H) P15 and (I) P90 WT vs JNK1KO mice. (J-O) Morphology and morphometry of WT 
vs JNK1KO  NG2+ OPCs. (J) Representative images of P7 WT vs JNK1 KO  NG2+ OPCs (red) in supragranular 
and infragranular layers of the cortex and in the CC, with related Imaris reconstruction (panels on the right). 
(K, L) Quantifi ation of the soma area (K) and of the territory occupied by OPC ramifi ations (L) in P7 and P90 
WT vs JNK1 KO mice. (M–O) Quantifi ation, through Neurolucida reconstruction, of the number of primary 
ramifi ations (M), mean length (N) and complexity (O) of the ramifi ations in P90 WT vs JNK1 KO  NG2+ 
OPCs. Asterisks in (O): Two-way ANOVA, main effect of genotype. Scale bars: 100 μm in (A), 100 μm in (F), 
20 μm in (L). WT wild type, P postnatal day, PDGFRα platelet-derived growth factor receptor A, NG2 neural/
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Figure 4.  JNK1KO OPCs show higher proliferation and less complex ramifi ations in vitro. (A) Representative images of MACS-
sorted cultured WT or JNK1 KO  NG2+ (red) OPCs.  Ki67+ proliferating cells (green) are indicated by white arrows. DAPI (blue) 
counterstains cell nuclei. (B) Quantifi ation of WT vs JNK1 KO MACS-sorted proliferating OPCs. In (C) the proliferative fraction 
 (Ki67+ OPCs over all OPCs) is plotted as a function of the number of OPCs in each analyzed fi ld. The result of this analysis was 
also confi med excluding the WT leverage points. (D) Representative image of MACS-sorted cultured JNK1 KO OPCs in high cell 
density. (E) Representative images of WT vs JNK1 KO MACS-sorted  NG2+ OPCs (red). DAPI (blue) counterstains cell nuclei. (F–I) 
Quantifi ation, through Neurolucida reconstruction, of soma areas (F), number of primary ramifi ations (G), total length (H) and 
complexity (I) of the ramifi ations of WT vs JNK1 KO MACS-sorted OPCs. (J) Sholl analysis of WT vs JNK1 KO MACS-sorted OPCs. 
Asterisks in (I) and (J): Two-way ANOVA (main effect of genotype). Scale bars: 50 μm in (A) and in (D). WT wild type, NG2 neural/
glial antigen 2, Ki67 Ki67 antigen. *P < 0.05; **P < 0.01; ****P < 0.0001.
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Our data further showed that JNK1 KO OPCs proliferation and density in vivo are increased only during 
developmental stages. Although OPC amplifi ation, self-maintenance and maturation at adult stage are supposed 
to recapitulate the corresponding developmental  processes55, to what extent the very same molecular mechanisms 
subserve these events in the postnatal vs adult CNS is unclear. Age-dependent differences in gene expression and 
function occur in OPCs. In particular, early OPCs are more proliferative, characterized by a shorter cell cycle and 
more susceptible to JNK-dependent  death24, 56–58. Whether and how JNK1 is involved in postnatal vs adult OPC 
distinct properties remains elusive. We can also speculate that supernumerary JNK1 KO OPCs may be simply 
eliminated in parallel with the progression of myelination, thereby adjusting the number of OLs to that of the 
axons (and to limiting amounts of trophic factors provided by axons)59, as normally occurs in WT  brains60, 61.
JNK1 signaling has also been reported to participate in cell death which could impact on proliferation rates 
and cell densities. JNK pathway was shown to promote apoptosis in OPCs/OLs under stress  conditions62–64. 
However, if JNK1 isoform is implicated in physiological cell death is unknown. In in vivo analyses we did not fi d 
evidence of an altered apoptosis rate in JNK1 KO OPCs. Conversely, in MACS-sorted JNK1 KO OPCs cultures, 
we found an increased fraction of apoptotic cells. Such a fraction, similar to what occurs for WT cells, appeared 
to decline with increasing cell densities, in agreement with an increased production of survival signals at sites 
with high cellularity. These data overall suggest that the mechanisms underlying the physiological regulation 
of apoptosis are maintained in mutant cells, and increased apoptosis may simply reflect the increased number 
of JNK1 KO OPCs. Th s may imply that, in OPCs, JNK isoforms other than JNK1 regulate this aspect, or can 
compensate for JNK1 ablation in the physiological regulation of apoptosis.
JNK1 role in OPC architecture. Our analyses also provided evidence of a transient alteration of OPC 
territory occupancy. Voronoi polygons and cell territory analyses (Fig. 3F–I,K,L) show that, at least during devel-
opment, OPC territory in JNK1 KO is signifi antly reduced. Although at adult stages this gross OPC alteration 
seems to be restored, adult JNK1 KO OPCs displayed a reduction in ramifi ation length and branching com-
plexity (Fig. 3J–O). These defects were also recapitulated in cell culture analyses (Figs. 4E–J, 5C–D), confi ming 
Figure 5.  D-JNKI-1 treatment of rat OPCs mimics JNK1 KO in vitro. (A) Representative images and (B) 
quantifi ation of proliferative rat  NG2+ CTRL vs D-JNKI-1-treated OPCs (red).  Ki67+ proliferating cells (white) 
are indicated by white arrows. (C) Representative images and (D) Sholl analysis of CTRL vs D-JNKI-1-treated 
OPCs (red). DAPI (blue) counterstains cell nuclei. Asterisks in (D) Two-way ANOVA (main effect of genotype). 
Scale bars: 50 μm in (A) and 20 μm in (C). CTRL control cells, D-JNKI-1 JNK1 inhibitor-treated cells, NG2 
neural/glial antigen 2, Ki67 Ki67 antigen. *P < 0.05; **P < 0.01; ****P < 0.0001.
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Figure 6.  JNK1 KO and D-JNKI-1 treated OLs can differentiate and produce MBP. (A) Representative images 
and (B) quantifi ation of differentiated  MBP+ WT vs JNK1 KO OLs (green). DAPI (blue) counterstains cell nuclei. 
(C) Quantifi ation of the percentage of immature and mature WT vs JNK1 KO OLs. (D) Quantifi ation of the 
 MBP+ lamelliform territory occupied by WT vs JNK1 KO OLs. (E) Representative images and (F) quantifi ation 
of differentiated  MBP+ CTRL vs D-JNKI-1 treated OLs (green). DAPI (blue) counterstains cell nuclei. (G) 
Quantifi ation of the percentage of immature and mature CTRL vs D-JNKI-1 treated OLs. (H) Quantifi ation of 
the  MBP+ lamelliform territory occupied by CTRL vs D-JNKI-1 treated OLs. Scale bars: 50 μm in (A) and (E). WT 
wild type, MBP Myelin Basic Protein, CTRL control cells, D-JNKI-1 JNK1 inhibitor-treated cells. *P < 0.05.
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the cell autonomous role of JNK1. These fi dings might also refl ct the persistence of less complex immature 
phenotypes associated with the increased proliferative activity of the mutant cells. However, the maintenance 
of morphological alterations at adult ages, when mutant cell proliferation has declined back to WT levels, sup-
ports an involvement of JNK1 in OPC cytoskeletal dynamics independent of proliferative events, as previously 
found in  neurons17, 65. In keeping with this possibility, one potential JNK1 effector candidate in the regula-
tion of OPC cytoskeleton is the microtubule-associated protein 1B (MAP1B), expressed both in neurons and 
 oligodendrocytes66, that regulates microtubule elongation and dynamics. MAP1B is activated by kinases includ-
ing JNK through  phosphorylation67, and in neurons is known to support axon outgrowth. Notably, among the 
JNK isoforms, JNK1 appears to be particularly involved in the process of axonal  elongation68. In oligodendro-
glia, MAP1B is expressed in OPCs progressing toward the preoligodendrocyte  stages66, 69, 70—a transition that 
involves profound morphological changes—suggesting that its deregulated activation in the absence of JNK1 
could participate in the altered branching of mutant OPCs. Another possible target of JNK1 in the regulation of 
OPC cytoskeleton is mTOR. Both molecules act in parallel or via cross-regulation in many pathological contexts, 
where JNK seems to positively regulate mTOR  activity71.
JNK isoform 1 appears to play a predominant role in oligodendroglia. In further support of JNK1 
functions in oligodendrocytes, we found that mutant cell proliferative and morphological alterations were reca-
pitulated in WT OPCs treated with D-JNKI-136. Th s inhibitor is able to block JIP-JNK interaction, thus pre-
venting the phosphorylation of c-Jun, the main downstream target of all JNK isoforms, and of the other JBD 
 targets38, 72. Thus, this treatment might have revealed a much broader impact on the cells. However, D-JNKI-1 
administration well recapitulated the proliferative and morphological phenotype of JNK1 KO OPCs, suggest-
ing that JNK1, among the three JNK isoforms, has a predominant role in the regulation of OPC proliferation, 
branching and membrane extension. Th s hypothesis is also supported by qRT-PCR data of MACS-sorted OPCs 
(Suppl. Fig.  4C–E), revealing the absence of any compensatory upregulation or dysregulated expression the 
other two JNK isoforms.
In conclusion, our study shows that JNK1 ablation results in persistent myelin abnormalities in vivo and that 
JNK1 participates in a cell-autonomous manner in the regulation of OPC proliferation, branching architecture 
and membrane extension at mature stages, unveiling a novel player in the complex regulatory network of OPC 
biology. Further investigations are needed to disentangle the potential contribution of axonal vs oligodendroglial 
alterations in the hypomyelination phenotype in vivo. Finally, it is also interesting to note that most of the altera-
tions that we reported in mutant oligodendroglia (i.e. contact-mediated regulation of OPC proliferation, OPC 
branching architecture and paranodal organization) are regulated by NT-1  signaling7, 73–75. Further studies are 
needed to clarify whether NT-1 acts via JNK1 in oligodendroglia, as formerly shown in  neurons76, 77.
Methods
Experimental animals. For histological analyses and Magnetic-Activated Cell Sorting (MACS) we 
employed JNK1  KO78 and age-matched wild-type (WT) mice as controls. Perfusions of juvenile and adult 
mice were carried out under deep general anaesthesia obtained by intraperitoneal administration of ketamine 
(100 mg/kg; Ketavet; Bayern; Leverkusen, Germany) supplemented by xylazine (5 mg/kg; Rompun; Bayer). For 
OPCs cultures, postnatal (P0-P1) mice and rats were anesthetized on melting ice. Groups of 4–5 mice were 
housed in transparent polycarbonate cages (Tecnoplast, Buggirate, Italy) provided with sawdust bedding, boxes/
tunnels hideout as environmental enrichment and striped paper as nesting material. Food and water were pro-
vided ad libitum; environmental conditions were 12 h/12 h light/dark cycle, room temperature 21 °C ± 1 °C and 
room humidity 55% ± 5%.
The experimental plan was designed according to the guidelines of the NIH, the European Communities 
Council (2010/63/EU) and the Italian Law for Care and Use of Experimental Animals (DL26/2014). It was also 
approved by the Italian Ministry of Health (Authorization 1112/2016 prot E669C.20) and the Bioethical Com-
mittee of the University of Turin. The study was conducted according to the ARRIVE guidelines.
Histological procedures. Animals were anaesthetized and transcardially perfused with 4% paraformal-
dehyde (PFA) in 0.1 M phosphate buffer (PB). Brains were post-fi ed for 1 or 5 h (for immunofluorescence 
or Nissl/Gallyas staining, respectively), cryoprotected, and processed. Brains were cut in sagittal sections, for 
Gallyas stain of myelin using silver  nitrate79, 80. Otherwise, brains were cut in 40  µm thick coronal sections 
and then treated in order to detect the expression of the following antigens: NG2 (1:200, Millipore, Billerica, 
MS, USA); PDGFRα (APA-5 clone, 1:300, BD Biosciences, San Jose, CA, USA); MBP (Smi-99 clone, 1:1000 
Sternberger); SMI31 (1:500, SMI-31R Sternberger); CASPR (1:1000, Abcam); cCASPase-3 (1:200, Cell Signal-
ing); Ki67 (1:750, Invitrogen). Incubation with primary antibodies was made overnight at 4 °C in PBS with 2% 
Triton-X 100. The sections were then exposed for 2 h at room temperature (RT) to secondary Cy3−/ Cy2− (Jack-
son ImmunoResearch Laboratories, West Grove, PA), Alexafluor 647- (Molecular Probes Inc, Eugene, Oregon) 
conjugated antibodies. 4,6-diamidino-2-phenylindole (DAPI, Fluka, Milan, Italy) was used to counterstain cell 
nuclei. Sections were mounted on microscope slides with Tris-glycerol supplemented with 10% Mowiol (Calbio-
chem, LaJolla, CA). TUNEL assay was performed using the TMR red In Situ Cell Death Detection Kit (Roche, 
Basel, Switzerland) according to the manufacturer’s protocol.
Cell cultures. After tissue dissociation with a papain + DNAseI solution (papain 1.5  mg/ml, l -cysteine 
360 µg/ml, DNAseI 1000U/ml in MEM; all from Sigma-Aldrich, Saint Louis, MS, USA), mouse OPCs were 
enriched by positive selection using an anti-PDGFRα antibody conjugated to magnetic beads, according to the 
instructions of the manufacturer (Miltenyi Biotech GmbH, Bergisch Gladbach, DE). MACSorted OPCs were 
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plated onto poly-d-lysine (1 µg/ml, Sigma-Aldrich, Saint Louis, MS, USA) coated glass coverslips in a prolif-
erative medium including Neurobasal, 1X B27 (Invitrogen, Milan, Italy), 2 mM l -glutamine (Sigma-Aldrich, 
Saint Louis, MS, USA), 10 ng/ml PDGF-BB and 10 ng/ml human bFGF (Miltenyi Biotech GmbH, Bergisch 
Gladbach, DE), or processed for quantitative RT-PCR analysis. Purity of the MACS-selected OPCs was verifi d 
by immunocytochemistry (more than 95% of the cells were NG2-positive (+) at 6 h post-plating). Cells were 
cultured 3DIV in proliferative medium (described above) and fi ed. Alternatively, they were maintained 1DIV 
in proliferative medium and 6DIV in non-proliferative medium—Neurobasal, 1X B27 (Invitrogen, Milan, Italy), 
2 mM l -glutamine (Sigma-Aldrich, Saint Louis, MS, USA)—to allow differentiation, and subsequently fi ed.
To test the effect of D-JNKI-1 treatment, primary rat OPCs were isolated by the shaking method from mixed 
glial cultures obtained from P0-1 Sprague–Dawley rat cortex, as described  in5. OPCs were plated onto poly-
D-lysine (1 µg/ml, Sigma-Aldrich) -coated 12-mm glass coverslips for immunocytochemistry (5 ×  104 cells/
coverslip) in the proliferative medium (see above). After 1 day in vitro (DIV), the cell permeable JNK-inhibitor 
D-JNKI-1 (2 µM)36 was added to the medium until fixation (after 3DIV or 7DIV in proliferative or non-prolif-
erative conditions, respectively).
After 3 or 7 DIV, OPCs/OLs (both from mice and rats) were then fi ed for 20 min at RT with 4% PFA in 
0.1 M PB and labelled with anti-NG2 (1:400, Millipore, Billerica, MS, USA), -Ki67 (1:1000, Novocastra), -cCAS-
Pase-3 (1:400, Cell Signaling) and -MBP (Smi-99 clone, 1:1000 Sternberger) antibodies overnight at 4 °C in PBS 
with 0.25% Triton-X. Then, coverslips were incubated with Cy3−/Cy2− (Jackson ImmunoResearch Laboratories, 
West Grove, PA) and Alexafluor647- conjugated secondary antibody (Molecular Probes, Eugene, Oregon) for 
1-h RT. After a 5-min incubation with DAPI (1:1000, Fluka, Saint Louis, USA), coverslips were mounted with 
Tris-glycerol supplemented with 10% Mowiol (Calbiochem, LaJolla, CA).
In vivo cell counting, 3D reconstructions, densitometric and morphological analyses. His-
tological specimens were examined using a Leica TCS SP5 (Leica Microsystems, Wetzlar, Germany) confocal 
microscope. Quantitative evaluations (i.e. PDGFRα+ cell density, density and fraction of cell duplets,  NG2+/
Ki67+ cell density,  cCASP3+/NG2+ cell density, 3D-reconstruction of the corpus callosum) were performed by 
means of the Neurolucida system (MicroBrightfi ld, Colchester, VT).
The extent of MBP/SMI31 or CASPR staining was quantifi d with ImageJ (Research Service Branch, National 
Institutes of Health, Bethesda, MD; available at http:// rsb. info. nih. gov/ ij/) as percentage of positive pixels over an 
area of 0.15  mm2 in confocal image stacks comprising 16 optical slices 0.99 µm thick (for MBP/SMI31) or over 
an area of 0.015  mm2 in confocal image stacks comprising 5 optical slices 0.99 µm thick (for CASPR). Confocal 
images (1024 × 1024 pixels) of MBP/SMI31 or CASPR immunostaining were all acquired with a speed of 200 Hz 
with the same settings (i.e. pinhole size: MBP, 67.9 µm; SMI31, 67.9 µm; CASPR, 67.9 µm; laser power: MBP, 
80%; SMI31, 28%; CASPR, 10%; gain: MBP, 484.0 V; SMI31, 570.0 V; CASPR, 570.0; offset: MBP, − 2%; SMI31, 
− 1.4%; CASPR, − 3%) and analyzed after ImageJ default auto-thresholding (i.e. IJ_IsoData). Voronoi analysis 
of the cell distribution was performed with ImageJ while cell territory and soma area were analyzed with Imaris 
(Bitplane) software (only cells whose entire extension was completely included in the confocal stack were con-
sidered). The number of inspected cells ranged from 46 to 70 cells per individual, with a total of ~ 300/350 cells 
per genotype. Primary ramifi ations, ramifi ation length and complexity of branching analyses were performed 
with the Neurolucida system (MicroBrightfi ld, Colchester, VT). The analysis of the complexity of branching was 
performed assigning progressive numbers (i.e. orders) to branches extending directly from the cell soma (order 
1) and then to all processes centrifugally emerging from subsequent branches (order > 1), to describe the hier-
archy of the branching scheme. Each tree (i.e. each primary ramifi ation (order 1) associated with its branching 
scheme) was analyzed individually. Plotted values (Figs. 3O,4I) represent the mean of all analyzed trees. OPCs 
juxtaposed with symmetrical cell somata and decondensed grainy DNA were recognized as duplets of cells that 
exited cytokinesis after cell  division5, 81, 82. As such, OPC duplets were counted in tissue slices to measure OPC 
proliferative  activity32. OPC proliferation was also evaluated by counting  NG2+/Ki67+ double positive cells. 
Adobe Illustrator 6.0 (Adobe Systems, San Jose, CA) was used to assemble the fi al plates. In all the analyses the 
experimenter was blind to the genotype of the samples.
In vitro cell counting and morphological analyses. Expression of Ki67/cCASP3 in cultured OPCs and 
of MBP in cultured OLs was investigated live in five to eight quadrants localized in central and peripheral areas 
of each coverslip—as described  in83—with the Neurolucida software. Results for each quadrant were expressed 
as a percentage of marker-positive cells over the number of OPCs and averaged across different coverslips. For 
reconstructing OPC arborizations, 20–30 non-proliferative (Ki67- negative) OPCs/coverslip isolated from other 
cells were randomly selected and traced live with the Neurolucida software, with a total of ~ 60–70 inspected cells 
per condition. Cultured  MBP+ OLs were categorized in immature/mature OLs depending on the localization of 
 MBP+ staining (restricted to ramifi ations for immature cells or further expanded to lamellae-like membranes 
for mature cells) and on the complexity of their processes (poorly branched for immature cells and complexly 
branched for mature cells, as described  in84). The surface occupancy of  MBP+ lamelliform OLs was analyzed 
with ImageJ. The number of inspected cells ranged from 15 to 25 cells per coverslip, with a total of ~ 80/100 cells 
per condition. In all cell counting and morphological analyses the experimenter was blind to the genotype or 
treatment of the cells.
Quantitative RT‑PCR. Total RNA from MACS-sorted OPCs was extracted with the Direct-zol RNA Mini-
prep kit (Zymo Research, Irevine, USA), and reverse transcribed to cDNA with the High-Capacity cDNA Archive 
kit (Applied Biosystems, Thermofisher, Waltham, USA). Quantitative Real Time RT-PCR was performed as 
described  in85, either with pre-developed Taqman assays (Applied Biosystems, Thermofisher, Waltham, USA) 
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or by combining the RealTime Ready Universal Probe Library (UPL, Roche Diagnostics, Monza, Italy) with 
the primers indicated in Suppl. Table 1. A relative quantifi ation approach was used, according to the  2-ddCT 
 method86. β-actin was used to normalize expression levels.
Tissue dissection, lysates and western blotting. CC and cortices from P7, P15 and P30 WT and 
JNK1KO mice, after brain sectioning with Leica vibratome, were obtained by dissection. Tissue lysates were 
obtained adding RIPA buffer (1% NP40, 150 mM NaCl, 50 mM TRIS HCl pH 8, 5 mM EDTA, 0.01% SDS, 
0.005% Sodium deoxycholate, Roche protease inhibitors, PMSF) for 10 min at 4 °C. Samples were homogenized 
on ice with a pellet pestle (Sigma-Aldrich, Saint Louis, MS, USA) and centrifuged at 1300 rpm at 4 °C. For immu-
noblots, equal amounts of proteins were resolved by SDS–PAGE and blotted to nitrocellulose membranes, which 
were then probed with anti-MBP (1:1000, Millipore, Billerica, MS, USA—MW: 18–21 kDa), -CNPase (1:500, 
Sigma-Aldrich, Saint Louis, MS, USA—MW: 47  kDa), -MOG (1:1000, Proteintech, Manchester, UK—MW: 
25 kDa) and -SMI31 (1:1000, SMI-31R Sternberger—MW: 160–200 kDa) antibodies. The membranes were sub-
sequently incubated with the secondary antibodies and developed using the Luminata Forte HRP substrate (Mil-
lipore, Billerica, MS, USA). Signals are normalized using anti-β-Tubulin (1:5000, Sigma-Aldrich, Saint Louis, 
MS, USA—MW: 50 kDa) and anti-Vinculin (1:2000, Sigma-Aldrich, Saint Louis, MS, USA—MW: ~ 120 kDa) 
antibodies. Blots were imaged on a ChemiDoc (Bio-Rad) and analyzed using Image Lab software.
Statistical analyses. In all histological quantifi ations, at least three animals and three sections per animal 
were analyzed for each time point and experimental condition. Western blotting analyses were performed with 
three animals for each time point and experimental condition, with at least three technical replicates. For in vitro 
experiments, at least three experiments were performed, each with at least two technical replicates per condition. 
Statistical analyses were carried out with GraphPad Prism 7 (GraphPad software, Inc). The Shapiro–Wilk test 
was fi st applied to test for a normal distribution of the data. When normally distributed, unpaired Student’s t 
test (to compare two groups) and Two-way ANOVA test (for multiple group comparisons) followed by Sidak’s 
post hoc analysis were used. Statistics also included Chi-square test (to compare frequencies) and linear regres-
sion analysis (to analyze in vitro OPC proliferation and apoptosis in relation to cell density). In all instances, 
P < 0.05 was considered as statistically signifi ant. Histograms represent mean ± standard error (SE). Statistical 
differences were indicated with *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. The list of the applied tests, F 
values and values for n (animals for in vivo analyses, experiments for in vitro analyses), results of post hoc analy-
ses are included in Supplementary Table 2. Supporting data are available within the article or can be provided 
upon request.
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